Advertisement

Topics

German Merck shows new data backing BTK drug evobrutinib in MS

09:22 EDT 13 May 2019 | pharmaphorum

Germany’s Merck KGaA has announced new mid-stage data that it says support further studies into its BTK inhibitor drug evobrutinib in multiple sclerosis, which could provide patients with a new oral therapy for the disease. Bruton’s tyrosine kinas...

Original Article: German Merck shows new data backing BTK drug evobrutinib in MS

NEXT ARTICLE

More From BioPortfolio on "German Merck shows new data backing BTK drug evobrutinib in MS"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...